Brand name – Natdac
Generic name – Daclatasvir dihydrochloride
Manufacturer – Natco Pharma Ltd.
Salt composition – Daclatasvir dihydrochloride
Storage – Store at room temperature (10-30°C)
Dosage form – Oral (tablet)
Strength – 30mg and 60mg
Packaging – Bottle
Gender – Unisex
Prescription required – Yes
Indication – Used in the treatment of chronic Hepatitis C Virus (HCV) infection
Description
Natdac (Daclatasvir dihydrochloride) tablet is an antiviral medicine. It is available in two strengths: 30 mg and 60 mg. It is used along with other prescribed medicines in the treatment of chronic (long-lasting) Hepatitis C Virus (HCV) infection in adults. Natdac (Daclatasvir dihydrochloride) tablet lowers the multiplication of virus in the body and thereby, improves the functioning of the body. The active ingredient of the Natdac tablet is Daclatasvir dihydrochloride.
Pharmacodynamics
Natdac is a direct-acting antiviral agent (DAA), that works against the Hepatitis C Virus.
At a dose three times the maximum recommended dose, Natdac did not prolong the QT interval to any clinically relevant extent.
Contraindication
Do not take this medicine in case you have a known allergy to any of the ingredients (active or/and inactive) of the medicine.
Alternate brands
● Daclacure tablet
● Dacihep tablet
● Lupidec tablet
● Dalsiclear tablet


